8-K: Health In Tech Q2 2026 Earnings: Focus Shifts to Contracted Revenue

Sentiment:

Current Report (Earnings Call Transcript)


Health In Tech reported a year-over-year decrease in GAAP revenue for Q2 2026 due to a new carrier onboarding timing shift, but highlighted significant growth in contracted and pipeline revenue as key indicators of future performance.

Worse than expectedReported GAAP revenue for Q2 2026 was $8.1 million, down 13.5% from $9.3 million in Q2 2025.Net loss for Q2 2026 was $2.5 million, compared to a net income of $0.6 million in Q2 2025.Adjusted EBITDA was negative $1.3 million for Q2 2026, compared to positive $1.6 million in Q2 2025.

Summary

  • Health In Tech hosted its Q2 2026 earnings call on August 13, 2026, to discuss financial and operating results.
  • The company is undergoing a significant technology shift, modernizing the self-funded health insurance market with an AI-enabled platform.
  • Reported GAAP revenue for Q2 2026 was $8.1 million, a decrease from $9.3 million in Q2 2025, attributed to a timing shift from onboarding a new carrier.
  • Management emphasized that this was not a demand, churn, or platform issue, but a timing factor that will benefit long-term growth.
  • Contracted Revenue (revenue committed under active policies not yet recognized) was $32.3 million for H1 2026, with $14.0 million expected in H2 2026 and $1.0 million in 2027.
  • Pipeline Revenue (policies in quoting/binding status) stood at $66.3 million as of July 31, 2026, with an expected conversion rate of 15% to 40%.
  • The company reaffirmed its full-year 2026 revenue guidance of $45 million to $50 million.
  • Adjusted EBITDA was negative $1.3 million for Q2 2026 and negative $2.6 million for H1 2026, reflecting planned investments in growth.
  • Net loss for Q2 2026 was $2.5 million ($0.04 per diluted share), compared to a net income of $0.6 million ($0.01 per diluted share) in Q2 2025.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a cautiously optimistic report. While GAAP revenue declined year-over-year, management effectively explained the timing-related reasons and emphasized strong growth in contracted and pipeline revenue, indicating future potential.

Positives

  • Distribution partner network grew to 933 brokers, third-party administrators, and agencies, up 19.9% year-over-year.
  • Significant platform updates were rolled out, including enhanced Census Insights, expanded large-group quoting, automated experience data parsing, AI-driven risk insights, and direct broker-to-underwriter messaging.
  • Secured the first employer group under the Three-Year Rate Stabilization Program, a key milestone for its anticipated capital markets launch.
  • On track to launch HitRix, a new marketplace platform for the large group self-funded stop-loss market, in the second half of 2026.
  • Contracted Revenue for H1 2026 reached $32.3 million, indicating strong future revenue visibility.
  • Pipeline Revenue as of July 31, 2026, was $66.3 million, suggesting substantial future business opportunities.
  • Reaffirmed full-year 2026 revenue guidance of $45 million to $50 million.
  • Operating cash used improved to $2.9 million in Q2 2026 compared to $3.3 million in Q1 2026.
  • The company's platform has helped employers avoid hundreds of thousands of dollars in unnecessary costs.

Negatives

  • Reported GAAP revenue for Q2 2026 was $8.1 million, down 13.5% from $9.3 million in Q2 2025.
  • Net loss for Q2 2026 was $2.5 million ($0.04 per diluted share), compared to a net income of $0.6 million ($0.01 per diluted share) in Q2 2025.
  • Net loss for H1 2026 was $4.1 million ($0.07 per diluted share), compared to net income of $1.1 million ($0.02 per diluted share) in H1 2025.
  • Adjusted EBITDA was negative $1.3 million for Q2 2026 and negative $2.6 million for H1 2026, compared to positive figures in the prior year.
  • Total operating expenses increased to $7.4 million in Q2 2026 from $5.6 million in Q2 2025, driven by investments in sales, marketing, and technology.
  • Sales and marketing expenses doubled to $2.2 million in Q2 2026 from $1.2 million in Q2 2025.
  • Accounts receivable days increased to 55 days in H1 2026 from 20 days in H1 2025, though management stated this is not uncommon.
  • Cash and cash equivalents decreased to $6.5 million at quarter-end from $8.1 million a year ago.

Risks

  • Forward-looking statements involve known and unknown risks, uncertainties, and other factors that could cause actual results to differ materially from those expressed or implied.
  • Risks and uncertainties are detailed in the company's Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and other SEC filings.
  • The company's ability to scale its platform to serve thousands of brokers, larger carriers, and larger employer groups is subject to execution and market adoption.
  • The success of the HitRix platform launch in the large group self-funded stop-loss market is subject to market acceptance and competitive pressures.
  • The Three-Year Rate Stabilization Program's success and anticipated launch in capital markets depend on market conditions and regulatory approvals.
  • The company's reliance on technology infrastructure and AI capabilities carries inherent risks related to development, implementation, and security.

Future Outlook

The company reaffirmed its full-year 2026 revenue guidance of $45 million to $50 million. Management expects to launch the HitRix platform in the second half of 2026 and anticipates providing further updates on the Three-Year Rate Stabilization Program in the coming months.

Management Comments

  • "We have built a marketplace that is connecting brokers, third-party administrators and carriers into one secured, AI enabled health insurance platform that is efficient, transparent, and ultimately, reduces costs through removing frictions."
  • "Our platform doesnt just speed up a form it ingests census data, parses experience data automatically, enables the carrier to build its specific underwriting criteria in-system in real time, and returns a bindable, execution-ready quote in a fraction of the time it takes using legacy tools."
  • "This is not a company that should be judged quarter-by-quarter on a single reported revenue line. This is a young, still-evolving platform business... with a business model that generates contractually locked-in revenue well ahead of when that revenue actually gets recognized on our income statement."
  • "The GAAP revenue number reflects a timing shift, not a change in the trajectory of the business, and we believe contracted revenue and platform placed plan value are the clearest windows into where this Company is actually headed."
  • "Health In Tech was not built to be a marginally better version of how self-funded insurance has always been sold. We built this Company to replace a process that has been slow, opaque, and expensive for employers for decades and we are doing exactly that, every single day, at scale."

Industry Context

StockSavvy.ai notes that Health In Tech is operating in the rapidly evolving health insurance technology sector, which is experiencing a significant shift towards AI-driven solutions and greater transparency. The company's focus on modernizing the self-funded insurance market, particularly by connecting brokers, TPAs, and carriers on a unified platform, addresses a substantial market opportunity that has historically been underserved by technology.

Comparison to Industry Standards

  • The company's AI-enabled platform aims to reduce inefficiencies in the self-funded health insurance market, which is estimated to be a nearly one trillion-dollar market.
  • Health In Tech's platform connects 933 brokers, TPAs, and agencies, representing a small fraction of the over one million insurance brokers nationwide.
  • The company's approach of building a comprehensive AI-enabled platform contrasts with many competitors who offer automation bolted onto legacy systems.
  • The HitRix platform is designed for the large group self-funded stop-loss market (100+ individuals), a segment characterized by complex claims data and manual processes, aiming to provide a competitive marketplace and real-time analytics.
  • The Three-Year Rate Stabilization Program aims to provide budgetary certainty for healthcare costs, a significant expense for corporations, particularly governmental agencies and municipalities.

Stakeholder Impact

  • Shareholders: Potential for future enterprise value growth driven by platform modernization and market penetration, despite short-term revenue decline.
  • Employers: Benefit from potential cost savings through AI-driven efficiencies, customized plans, and the Three-Year Rate Stabilization Program offering budgetary certainty.
  • Brokers: Enhanced tools and platform capabilities that streamline quoting, underwriting, and administration, improving efficiency and potentially close rates.
  • Carriers: Access to a broader distribution network and more efficient onboarding processes.
  • Employees: Continued investment in technology and growth may lead to expanded opportunities within the company.

Next Steps

  • Officially launch the HitRix platform in the second half of 2026.
  • Provide additional updates on the Three-Year Rate Stabilization Program in the coming months.
  • Continue to expand the distribution partner network and pipeline revenue.
  • Continue planned investments in sales, marketing, and technology to support long-term growth.

Key Dates

DateDescription
2023-01-01Accounts receivable days were 42 days.
2024-01-01Accounts receivable days were 29 days.
2025-01-01Accounts receivable days were 14 days.
2026-06-30Quarter ended June 30, 2026.
2026-07-31Pipeline Revenue stood at $66.3 million.
2026-08-13Date of the Form 8-K filing and the Q2 2026 earnings conference call.

Recommendation

hold

The company's GAAP revenue declined year-over-year, and profitability metrics (Adjusted EBITDA and Net Income) worsened compared to the prior year. However, management provided a strong rationale for the revenue decline, emphasizing the shift to contracted and pipeline revenue as leading indicators of future performance. The growth in distribution partners and the upcoming launch of new platforms (HitRix) suggest future potential. Given the mixed short-term results and the reliance on future growth drivers, a 'hold' recommendation is appropriate pending further clarity on the execution of these growth strategies and a return to GAAP profitability.

Keywords

Health Insurance, Self-funded Health Plans, AI Platform, Insurance Marketplace, Underwriting, Stop-loss Insurance, Broker Network, Enterprise Software

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.